|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 31/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 3212668 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15791213.0 |
| Date of filing the European patent application | 2015-10-30 | |
| (97) | Date of publication of the European application | 2017-09-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/058389 |
| Date | 2015-10-30 |
| (87) | Number | WO 2016/070089 |
| Date | 2016-05-06 |
| (30) | Number | Date | Country code |
| 201462073824 P | 2014-10-31 | US |
| (72) |
GISH, Kurt C., US
KIM, Han K., US
NAUMOVSKI, Louie, US
|
| (73) |
AbbVie Biotherapeutics Inc.,
1500 Seaport Boulevard, Redwood City, CA 94063,
US
|
| (54) | ANTI-CS1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
| ANTI-CS1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES |